AGEs and methylglyoxal induce apoptosis and expression of Mac-1 on neutrophils resulting in platelet-neutrophil aggregation

Thrombosis Research

Volumn 121, Issue 1, 2007, Pages 117-126

  Gawlowski, Thomas ^a   Stratmann, Bernd ^a   Stirban, Alin O ^a   Negrean, Monica ^a   Tschoepe, Diethelm ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

AGEs; Aggregation; Methylglyoxal; Thrombosis

Indexed keywords

ADVANCED GLYCATION END PRODUCT; BOVINE SERUM ALBUMIN; CELL ADHESION MOLECULE; CELL MARKER; METHYLGLYOXAL; PADGEM PROTEIN; THROMBOPLASTIN;

ADULT; APOPTOSIS; ARTICLE; BLOOD; CARDIOVASCULAR RISK; CELL AGGREGATION; CELL STIMULATION; CONTROLLED STUDY; DIABETES MELLITUS; DOSE RESPONSE; FEMALE; FLOW CYTOMETRY; HEMOSTASIS; HUMAN; HUMAN CELL; INCUBATION TIME; MALE; MITOCHONDRION; NEUTROPHIL; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PLATELET NEUTROPHIL AGGREGATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOCYTE ACTIVATION; THROMBOSIS;

APOPTOSIS; BIOLOGICAL MARKERS; BLOOD CELLS; BLOOD PLATELETS; CELL AGGREGATION; CELLS, CULTURED; GENE EXPRESSION REGULATION; GLYCOSYLATION END PRODUCTS, ADVANCED; HEMOSTASIS; HUMANS; MACROPHAGE-1 ANTIGEN; NEUTROPHILS; PYRUVALDEHYDE; THROMBOSIS; UP-REGULATION;

EID: 35649027401     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2007.03.002     Document Type: Article

References (46)

1. Ceriello A. Coagulation activation in diabetes mellitus: the role of hyperglycaemia and therapeutic prospects. Diabetologia 36 (1993) 1119-1125
2. Haffner S.M., Lehto S., Ronnemaa T., Pyorala K., and Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339 (1998) 229-234
3. Vlassara H., and Palace M.R. Diabetes and advanced glycation endproducts. J Intern Med 251 (2002) 87-101
4. Schiekofer S., Andrassy M., Chen J., Rudofsky G., Schneider J., Wendt T., et al. Acute hyperglycemia causes intracellular formation of CML and activation of ras, p42/44 MAPK, and nuclear factor kappaB in PBMCs. Diabetes 52 (2003) 621-633
5. Mauron J. The Maillard reaction in food; a critical review from the nutritional standpoint. Prog Food Nutr Sci 5 (1981) 5-35
6. O'Brien J., and Morrissey P.A. Nutritional and toxicological aspects of the Maillard browning reaction in foods. Crit Rev Food Sci Nutr 28 (1989) 211-248
7. Nicholl I.D., and Bucala R. Advanced glycation endproducts and cigarette smoking. Cell Mol Biol (Noisy-le-grand) 44 (1998) 1025-1033
8. Cooper M.E. Importance of advanced glycation end products in diabetes-associated cardiovascular and renal disease. Am J Hypertens 17 (2004) 31S-38S
9. Brownlee M., Cerami A., and Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 318 (1988) 1315-1321
10. Sell D.R., Lapolla A., Odetti P., Fogarty J., and Monnier V.M. Pentosidine formation in skin correlates with severity of complications in individuals with long-standing IDDM. Diabetes 41 (1992) 1286-1292
11. Yan S.D., Schmidt A.M., Anderson G.M., Zhang J., Brett J., Zou Y.S., et al. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J Biol Chem 269 (1994) 9889-9897
12. Tan K.C., Chow W.S., Ai V.H., Metz C., Bucala R., and Lam K.S. Advanced glycation end products and endothelial dysfunction in type 2 diabetes. Diabetes Care 25 (2002) 1055-1059
13. Bucala R., Tracey K.J., and Cerami A. Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. J Clin Invest 87 (1991) 432-438
14. Neumann A., Schinzel R., Palm D., Riederer P., and Munch G. High molecular weight hyaluronic acid inhibits advanced glycation endproduct-induced NF-kappaB activation and cytokine expression. FEBS Lett 453 (1999) 283-287
15. Okamoto T., Tanaka S., Stan A.C., Koike T., Kase M., Makita Z., et al. Advanced glycation end products induce angiogenesis in vivo. Microvasc Res 63 (2002) 186-195
16. Valencia J.V., Mone M., Zhang J., Weetall M., Buxton F.P., and Hughes T.E. Divergent pathways of gene expression are activated by the RAGE ligands S100b and AGE-BSA. Diabetes 53 (2004) 743-751
17. Shinohara M., Thornalley P.J., Giardino I., Beisswenger P., Thorpe S.R., Onorato J., et al. Overexpression of glyoxalase-I in bovine endothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycemia-induced increases in macromolecular endocytosis. J Clin Invest 101 (1998) 1142-1147
18. Lapolla A., Flamini R., Vedova A., Senesi A., Reitano R., Fedele D., et al. Glyoxal and methylglyoxal levels in diabetic patients: quantitative determination by a new GC/MS method. Clin Chem Lab Med 41 (2003) 1166-1173
19. Berlanga J., Cibrian D., Guillen I., Freyre F., Alba J.S., Lopez-Saura P., et al. Methylglyoxal administration induces diabetes-like microvascular changes and perturbs the healing process of cutaneous wounds. Clin Sci (Lond) 109 (2005) 83-95
20. Stratmann B., and Tschoepe D. Pathobiology and cell interactions of platelets in diabetes. Diab Vasc Dis Res 2 (2005) 16-23
21. Tschoepe D., Roesen P., Esser J., Schwippert B., Nieuwenhuis H.K., Kehrel B., et al. Large platelets circulate in an activated state in diabetes mellitus. Semin Thromb Hemost 17 (1991) 433-438
22. Tschoepe D., Rauch U., and Schwippert B. Platelet-leukocyte-cross-talk in diabetes mellitus. Horm Metab Res 29 (1997) 631-635
23. Tremoli E., Camera M., Toschi V., and Colli S. Tissue factor in atherosclerosis. Atherosclerosis 144 (1999) 273-283
24. Khechai F., Ollivier V., Bridey F., Amar M., Hakim J., and de Prost D. Effect of advanced glycation end product-modified albumin on tissue factor expression by monocytes. Role of oxidant stress and protein tyrosine kinase activation. Arterioscler Thromb Vasc Biol 17 (1997) 2885-2890
25. Bierhaus A., Illmer T., Kasper M., Luther T., Quehenberger P., Tritschler H., et al. Advanced glycation end product (AGE)-mediated induction of tissue factor in cultured endothelial cells is dependent on RAGE. Circulation 96 (1997) 2262-2271
26. Li N., Hu H., Lindqvist M., Wikstrom-Jonsson E., Goodall A.H., and Hjemdahl P. Platelet-leukocyte cross talk in whole blood. Arterioscler Thromb Vasc Biol 20 (2000) 2702-2708
27. Entman M.L., and Ballantyne C.M. Association of neutrophils with platelet aggregates in unstable angina. Should we alter therapy?. Circulation 94 (1996) 1206-1208
28. Libby P., and Simon D.I. Inflammation and thrombosis: the clot thickens. Circulation 103 (2001) 1718-1720
29. Hartz S., Menart B., and Tschoepe D. Leukocyte apoptosis in whole blood involves platelet-dependent coaggregation. Cytometry A 52 (2003) 117-121
30. Lupu C., Calb M., Ionescu M., and Lupu F. Enhanced prothrombin and intrinsic factor X activation on blood platelets from diabetic patients. Thromb Haemost 70 (1993) 579-583
31. Hu H., Li N., Yngen M., Ostenson C.G., Wallen N.H., and Hjemdahl P. Enhanced leukocyte-platelet cross-talk in type 1 diabetes mellitus: relationship to microangiopathy. J Thromb Haemost 2 (2004) 58-64
32. Yamagishi S., Yonekura H., Yamamoto Y., Katsuno K., Sato F., Mita I., et al. Advanced glycation end products-driven angiogenesis in vitro. Induction of the growth and tube formation of human microvascular endothelial cells through autocrine vascular endothelial growth factor. J Biol Chem 272 (1997) 8723-8730
33. Palabrica T., Lobb R., Furie B.C., Aronovitz M., Benjamin C., Hsu Y.M., et al. Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets. Nature 359 (1992) 848-851
34. McEver R.P., and Cummings R.D. Role of PSGL-1 binding to selectins in leukocyte recruitment. J Clin Invest 100 (1997) S97-S103
35. Noguera A., Sala E., Pons A.R., Iglesias J., MacNee W., and Agusti A.G. Expression of adhesion molecules during apoptosis of circulating neutrophils in COPD. Chest 125 (2004) 1837-1842
36. van Oostrom A.J., van Wijk J.P., Sijmonsma T.P., Rabelink T.J., and Castro Cabezas M. Increased expression of activation markers on monocytes and neutrophils in type 2 diabetes. Neth J Med 62 (2004) 320-325
37. Riboulet-Chavey A., Pierron A., Durand I., Murdaca J., Giudicelli J., and Van Obberghen E. Methylglyoxal impairs the insulin signaling pathways independently of the formation of intracellular reactive oxygen species. Diabetes 55 (2006) 1289-1299
38. Beisswenger P.J., Howell S.K., O'Dell R.M., Wood M.E., Touchette A.D., and Szwergold B.S. alpha-Dicarbonyls increase in the postprandial period and reflect the degree of hyperglycemia. Diabetes Care 24 (2001) 726-732
39. Vlassara H., and Palace M.R. Glycoxidation: the menace of diabetes and aging. Mt Sinai J Med 70 (2003) 232-241
40. Stirban A., Negrean M., Stratmann B., Gawlowski T., Horstmann T., Goetting C., et al. Benfotiamine prevents macro- and microvascular endothelial dysfunction and oxidative stress following a meal rich in advanced glycation end products in individuals with type 2 diabetes. Diabetes Care 29 (2006) 2064-2071
41. Chavakis T., Bierhaus A., Al-Fakhri N., Schneider D., Witte S., Linn T., et al. The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment. J Exp Med 198 (2003) 1507-1515
42. Ichikawa K., Yoshinari M., Iwase M., Wakisaka M., Doi Y., Iino K., et al. Advanced glycosylation end products induced tissue factor expression in human monocyte-like U937 cells and increased tissue factor expression in monocytes from diabetic patients. Atherosclerosis 136 (1998) 281-287
43. Misumi K., Ogawa H., Yasue H., Soejima H., Suefuji H., Nishiyama K., et al. Comparison of plasma tissue factor levels in unstable and stable angina pectoris. Am J Cardiol 81 (1998) 22-26
44. Seljeflot I., Hurlen M., Hole T., and Arnesen H. Soluble tissue factor as predictor of future events in patients with acute myocardial infarction. Thromb Res 111 (2003) 369-372
45. Ferro D., Saliola M., Meroni P.L., Valesini G., Caroselli C., Pratico D., et al. Enhanced monocyte expression of tissue factor by oxidative stress in patients with antiphospholipid antibodies: effect of antioxidant treatment. J Thromb Haemost 1 (2003) 523-531
46. Wu L. The pro-oxidant role of methylglyoxal in mesenteric artery smooth muscle cells. Can J Physiol Pharmacol 83 (2005) 63-68